MOLECULAR CLONING OF HUMAN THYROID STIMULATING HORMONE RECEPTOR GENE

Cover Page


Cite item

Full Text

Abstract

Producing of recombinant TSHR fragments opens up new possibilities in the development of immunochemical tests to detect stimulating and blocking antibodies to TSHR, in studying the role of the antigenic structure of TSHR in the pathogenesis of autoimmune diseases of the thyroid gland. The original mRNA sequence of the α-subunit of the thyroid stimulating hormone receptor, not containing nucleotide substitutions, was cloned. The obtained recombinant vector pVAX1-TSHR, prepared for transfection into cells of mammals and for the expression of the recombinant protein of the α-subunit of the thyroid stimulating hormone receptor.

About the authors

A. V. Zubkov

Federal State Budgetary Scientific Institution «I. Mechnikov Research Institute of Vaccines and Sera»

Author for correspondence.
Email: alex_zubkov@list.ru

M. D. PhD, Head of the Laboratory for Immunological Diagnostics of Endocrine Diseases,

Moscow

Russian Federation

M. A. Andreeva

Federal State Budgetary Scientific Institution «I. Mechnikov Research Institute of Vaccines and Sera»

Email: fake@neicon.ru

junior researcher, of the Laboratory for Immunological Diagnostics of Endocrine Diseases,

Moscow

Russian Federation

A. V. Sidorov

Federal State Budgetary Scientific Institution «I. Mechnikov Research Institute of Vaccines and Sera»

Email: fake@neicon.ru

Ph. D. Head of the Laboratory for Genetics of DNA viruses, 

Moscow

Russian Federation

A. V. Milovanova

Federal State Budgetary Scientific Institution «I. Mechnikov Research Institute of Vaccines and Sera»

Email: fake@neicon.ru

researcher of the Laboratory for Genetics of DNA viruses,

Moscow

Russian Federation

L. G. Butova

Federal State Budgetary Scientific Institution «I. Mechnikov Research Institute of Vaccines and Sera»

Email: fake@neicon.ru

Ph.D., leading researcher, of the Laboratory for Immunological Diagnostics of Endocrine Diseases, 

Moscow

Russian Federation

References

  1. Smith T. J. TSHR as a therapeutic target in Graves’ disease. Expert Opin Ther Targets. 2017; 21(4): 427– 432.
  2. Rapoport B., McLachlan S. M. TSH receptor cleavage into subunits and shedding of the A-subunit; a molecular and clinical perspective. Endocrine Reviews. 2016; 37(2): 114–34.
  3. Sanders J., Bolton J., Sanders P., Jeff reys J., Nakatake N., Richards T., Evans M., Kiddie A., Summerhayes S., Roberts E., Miguel R. N., Furmaniak J., Smith B. R. Eff ects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH. Thyroid. 2007; 17(2): 1195–1206.
  4. Furmaniak J., Sanders J., Núñez Miguel R., B. Rees Smith. Mechanisms of Action of TSHR Autoantibodies. Horm Metab Res. 2015; 47: 735–752.
  5. Parmentier M., Libert F., Maenhaut C., Lefort A., Gerard C., Perret J., Van Sande J., Dumont J. E., Vassart G. Molecular cloning of the thyrotropin receptor. Science. 1989; 246(4937): 1620–1622.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Zubkov A.V., Andreeva M.A., Sidorov A.V., Milovanova A.V., Butova L.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies